XORTX Therapeutics (XRTX) )XRTX) welcomes Dr. Michael Bumby as its Chief Financial Officer replacing James Fairbairn, the Company’s current Chief Financial Officer. Dr. Bumby, DVM, MBA, is currently a director and audit committee chair of MediPharm Labs (MEDIF) following their successful acquisition of VIVO Cannabis. where Dr. Bumby was CFO for six years.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRTX: